Literature DB >> 9119443

Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival.

E Broug-Holub1, G B Toews, J F van Iwaarden, R M Strieter, S L Kunkel, R Paine, T J Standiford.   

Abstract

To study the in vivo role of alveolar macrophages (AM) in gram-negative bacterial pneumonia in mice, AM were eliminated by the intratracheal (i.t.) administration of dichloromethylene diphosphonate encapsulated liposomes. Subsequently, the AM-depleted mice were infected i.t. with 100 CFU of Klebsiella pneumoniae, and the effects of AM depletion on survival, bacterial clearance, and neutrophil (polymorphonuclear leukocyte [PMN]) recruitment were assessed. It was shown that depletion of AM decreases survival dramatically, with 100% lethality at day 3 postinfection, versus 100% long-term survival in the control group. This increased mortality was accompanied by 20- to 27- and 3- to 10-fold increases in the number of K. pneumoniae CFU in lung and plasma, respectively, compared to those in nondepleted animals. This decreased bacterial clearance was not due to an impaired PMN recruitment; on the contrary, the K. pneumoniae-induced PMN recruitment in AM-depleted lungs was sevenfold greater 48 h postinfection than that in control infected lungs. Together with an increased PMN infiltration, 3- and 10-fold increases in lung homogenate tumor necrosis factor alpha (TNF-alpha) and macrophage inflammatory protein 2 (MIP-2) levels, respectively, were measured. Neutralization of TNF-alpha or MIP-2, 2 h before infection, reduced the numbers of infiltrating PMN by 41.6 and 64.2%, respectively, indicating that these cytokines mediate PMN influx in infected lungs, rather then just being produced by the recruited PMN themselves. Our studies demonstrate, for the first time, the relative importance of the AM in the containment and clearance of bacteria in the setting of Klebsiella pneumonia.

Entities:  

Mesh:

Year:  1997        PMID: 9119443      PMCID: PMC175109          DOI: 10.1128/iai.65.4.1139-1146.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Identification and characterization of macrophage inflammatory protein 2.

Authors:  S D Wolpe; B Sherry; D Juers; G Davatelis; R W Yurt; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation.

Authors:  M Ellis; S Gupta; S Galant; S Hakim; C VandeVen; C Toy; M S Cairo
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

3.  Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.

Authors:  R C Strunk; D M Eidlen; R J Mason
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 4.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

5.  Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.

Authors:  A Nakane; T Minagawa; K Kato
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

6.  Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

Authors:  W J Ming; L Bersani; A Mantovani
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

7.  Tumor necrosis factor causes bronchial hyperresponsiveness in rats.

Authors:  J C Kips; J Tavernier; R A Pauwels
Journal:  Am Rev Respir Dis       Date:  1992-02

8.  Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2.

Authors:  M Monick; J Glazier; G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1987-01

9.  Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage.

Authors:  R Moser; B Schleiffenbaum; P Groscurth; J Fehr
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

10.  Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.

Authors:  A S Cross; J C Sadoff; N Kelly; E Bernton; P Gemski
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  117 in total

1.  Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency.

Authors:  Alfred Ayala; Chun-Shiang Chung; Joanne L Lomas; Grace Y Song; Lesley A Doughty; Stephen H Gregory; William G Cioffi; Brian W LeBlanc; Jonathan Reichner; H Hank Simms; Patricia S Grutkoski
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Postinfluenza bacterial pneumonia: host defenses gone awry.

Authors:  Megan N Ballinger; Theodore J Standiford
Journal:  J Interferon Cytokine Res       Date:  2010-09       Impact factor: 2.607

Review 3.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

4.  Identification of early interactions between Francisella and the host.

Authors:  Lydia M Roberts; Shraddha Tuladhar; Shaun P Steele; Kristina J Riebe; Ching-Ju Chen; R Ian Cumming; Sarah Seay; Richard Frothingham; Gregory D Sempowski; Thomas H Kawula; Jeffrey A Frelinger
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

5.  Bombesin recovers gut-associated lymphoid tissue and preserves immunity to bacterial pneumonia in mice receiving total parenteral nutrition.

Authors:  R C DeWitt; Y Wu; K B Renegar; B K King; J Li; K A Kudsk
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

6.  Acute lung inflammation in Klebsiella pneumoniae B5055-induced pneumonia and sepsis in BALB/c mice: a comparative study.

Authors:  Vijay Kumar; Sanjay Chhibber
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

Review 7.  Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.

Authors:  Megan N Ballinger; Tracy R McMillan; Bethany B Moore
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Jan-Feb       Impact factor: 4.291

8.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

9.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Evaluation of early macrophage activation and NF-kappaB activity in pulmonary injury caused by deep hypothermia circulatory arrest: an experimental study.

Authors:  Jing-hao Zheng; Bo-tao Gao; Zu-ming Jiang; Xiao-qing Yu; Zhi-wei Xu
Journal:  Pediatr Cardiol       Date:  2009-12-03       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.